Red Cell Distribution Width (RDW) Index as a Predictor of Severity of Acute Ischemic Stroke: A Correlation Study

機(jī)譯：紅細(xì)胞分布寬度（RDW）指數(shù)作為急性缺血性卒中嚴(yán)重程度的預(yù)測(cè)指標(biāo)：一項(xiàng)相關(guān)性研究

代理獲取

本網(wǎng)站僅為用戶提供外文OA文獻(xiàn)查詢(xún)和代理獲取服務(wù)，本網(wǎng)站沒(méi)有原文。下單后我們將采用程序或人工為您竭誠(chéng)獲取高質(zhì)量的原文，但由于OA文獻(xiàn)來(lái)源多樣且變更頻繁，仍可能出現(xiàn)獲取不到、文獻(xiàn)不完整或與標(biāo)題不符等情況，如果獲取不到我們將提供退款服務(wù)。請(qǐng)知悉。

頁(yè)面導(dǎo)航

摘要
著錄項(xiàng)
引文網(wǎng)絡(luò)
相似文獻(xiàn)
相關(guān)主題

摘要

Globally, stroke is one of the leading causes of death and disability-adjusted life-years (DALYs). The red cell distribution width (RDW) is a readily available and inexpensive test which is done routinely as a part of complete blood count in these patients.

機(jī)譯：在全球范圍內(nèi)，中風(fēng)是導(dǎo)致死亡和殘疾調(diào)整生命年（DALYs）的主要原因之一。紅細(xì)胞分布寬度（RDW）是一種容易獲得且便宜的測(cè)試，通常作為這些患者全血細(xì)胞計(jì)數(shù)的一部分進(jìn)行。

著錄項(xiàng)

期刊名稱(chēng) Advanced Journal of Emergency Medicine
作者
Ritin Mohindra; Utkarash Mishra; Roshan Mathew; Narender Singh Negi;
展開(kāi)▼
作者單位

展開(kāi)▼
年(卷),期 2020(4),2
年度 2020
頁(yè)碼 -1
總頁(yè)數(shù) 6
原文格式 PDF
正文語(yǔ)種
中圖分類(lèi) 基礎(chǔ)醫(yī)學(xué);
關(guān)鍵詞
Correlation of Data; Erythrocyte Indices; Severity of Illness Index; Stroke;

機(jī)譯：數(shù)據(jù)的相關(guān)性;紅細(xì)胞指數(shù);疾病指數(shù)的嚴(yán)重程度;中風(fēng);

相似文獻(xiàn)

外文文獻(xiàn)
中文文獻(xiàn)
專(zhuān)利

1. Red cell distribution width and red cell distribution width to total serum calcium ratio as major predictors of severity and mortality in acute pancreatitis [J] . Marta Gravito-Soares, Elisa Gravito-Soares, Dário Gomes, BMC Gastroenterology . 2018,第1期

機(jī)譯：紅細(xì)胞分布寬度和紅細(xì)胞分布寬度與血清總鈣之比是急性胰腺炎嚴(yán)重程度和死亡率的主要預(yù)測(cè)指標(biāo)
2. Predicting the One-Year Prognosis and Mortality of Patients with Acute Ischemic Stroke Using Red Blood Cell Distribution Width Before Intravenous Thrombolysis [J] . Wei-Yi Ye, Jia Li, Xiang Li, Clinical Interventions in Aging . 2020,第2期

機(jī)譯：在靜脈內(nèi)溶栓前使用紅細(xì)胞分布寬度預(yù)測(cè)急性缺血性卒中患者的一年預(yù)后和死亡率
3. Red Blood Cell Distribution Width as a Predictor of Clinical Outcome in Acute Ischemic Stroke Patients [J] . Abdallh Al-Mà moun Sarhan, Khaled Aly El-Sharkawy, Takwa H M Elkhatib, International Journal of Clinical and Experimental Neurology . 2019,第1期

機(jī)譯：紅細(xì)胞分布寬度可作為急性缺血性卒中患者臨床療效的預(yù)測(cè)指標(biāo)
4. A New Interactive Visual-Aided Decision-Making Supporting Tool to Predict Severity of Acute Ischemic Stroke [C] . Gopichandh Danala, Sai Kiran Reddy Maryada, Morteza Heidari, Conference on Medical Imaging : Biomedical Applications in Molecular, Structural, and Functional Imaging . 2020

機(jī)譯：一種新的交互式視覺(jué)輔助決策，支持急性缺血性卒中的嚴(yán)重性
5. Prevalence of Anemia and Use of Red Cell Distribution Width as a Predictive Tool in a Bariatric Surgery Population. [D] . Peterson, Kelly. 2013

機(jī)譯：減肥手術(shù)人群中的貧血患病率和紅細(xì)胞分布寬度的使用作為預(yù)測(cè)工具。
6. Red Blood Cell Distribution Width (RDW) Predicts COVID-19 Severity: A Prospective Observational Study from the Cincinnati SARS-CoV-2 Emergency Department Cohort [O] . Brandon Michael Henry, Justin Lee Benoit, Stefanie Benoit, 2020

機(jī)譯：紅細(xì)胞分布寬度（RDW）預(yù)測(cè)Covid-19嚴(yán)重程度：來(lái)自辛辛那提SARS-COV-2急診部隊(duì)隊(duì)列的前瞻性觀察研究
7. Poster session 2Morphogenetic mechanisms290MiR-133 regulates retinoic acid pathway during early cardiac chamber specification291Bmp2 regulates atrial differentiation through miR-130 during early heart looping formationDevelopmental genetics294Association of deletion allele of insertion/deletion polymorphism in alpha 2B adrenoceptor gene and hypertension with or without type 2 diabetes mellitus295Association of G1359A polymorphism of the endocannabinoid type 1 receptor (CNR1) with coronary artery disease (CAD) with type 2 diabetes mellitusCell growth, differentiation and stem cells - Vascular298Gamma-secretase inhibitor prevents proliferation and migration of ductus arteriosus smooth muscle cells: a role of Notch signaling in postnatal closure of ductus arteriosus299Mesenchymal stromal-like cells (MLCs) derived from induced pluripotent stem (iPS) cells: a promising therapeutic option to promote neovascularization300Sonic Hedgehog promotes mesenchymal stem cell differentiation to vascular smooth muscle cells in cardiovacsular disease301Proinflammatory cytokine secretion and epigenetic modification in endothelial cells treated LPS-GinfivalisCell death and apoptosis - Vascular304Mitophagy acts as a safeguard mechanism against human vascular smooth muscle cell apoptosis induced by atherogenic lipidsTranscriptional control and RNA species - Vascular307MicroRNA-34a role in vascular calcification308Local delivery of a miR-146a inhibitor utilizing a clinically applicable approach attenuates neointima formation after vascular injury309Long noncoding RNA landscape of hypoxic endothelial cells310Specific circulating microRNAs levels associate with hypertension, hyperglycemia and dysfunctional HDL in acute coronary syndrome patientsCytokines and cellular inflammation - Vascular313Phosphodiesterase5A up-regulation in vascular endothelium under pro-inflammatory conditions: a newly disclosed anti-inflammatory activity for the omega-3polyunsaturated aatty acid docosahexaenoic acid314Cardiovascular risk modifying with extra-low dose anticytokine drugs in rhematoid arthritis315Conversion of human M-CSF macrophages into foam cells reduces their proinflammatory responses to classical M1-polarizing activation316Lymphocytic myocarditis coincides with increased plaque inflammation and plaque hemorrhage in coronary arteries, facilitating myocardial infarction317Serum osteoprotegerin level predictsdeclined numerous of circulating endothelial- derived and mononuclear-derived progenitor cells in patients with metabolic syndromeGrowth factors and neurohormones - Vascular320Effect of gastrin-releasing peptide (GRP) on vascular inflammationSignal transduction - Heart323A new synthetic peptide regulates hypertrophy in vitro through means of the inhibition of nfkb324Inducible fibroblast-specific knockout of p38 alpha map kinase is cardioprotective in a mouse model of isoproterenol-induced cardiac hypertrophy325Regulation of beta-adrenoceptor-evoked inotropic responses by inhibitory G protein, adenylyl cyclase isoforms 5 and 6 and phosphodiesterases326Binding to RGS3 and stimulation of M2 muscarinic acetylcholine receptors modulates the substrate specificity of p190RhoGAP in cardiac myocytes327Cardiac regulation of post-translational modifications, parylation and deacetylation in LMNA dilated cardiomyopathy mouse model328Beta-adrenergic regulation of the b56delta/pp2a holoenzyme in cardiac myocytes through b56delta phosphorylation at serine 573Nitric oxide and reactive oxygen species - Vascular331Oxidative stress-induced miR-200c disrupts the regulatory loop among SIRT1, FOXO1 and eNOS332Antioxidant therapy prevents oxidative stress-induced endothelial dysfunction and Enhances Wound Healing333Morphological and biochemical characterization of red blood cell in coronary artery diseaseCytoskeleton and mechanotransduction - Heart336Novel myosin activator, JSH compounds, increased myocardial contractility without chronotropic effect in ratsExtracellular matrix and fibrosis - Vascular339Ablation of Toll-like receptor 9 causes cardiac rupture after myocardial infarction by attenuating proliferation and differentiation of cardiac fibroblasts340Altered vascular remodeling in the mouse hind limb ischemia model in Factor VII activating protease (FSAP) deficiencyVasculogenesis, angiogenesis and arteriogenesis343Pro-angiogenic effects of proly-hydroxylase inhibitors and their potential for use in a novel strategy of therapeutic angiogenesis for coronary total occlusion344Nrf2 drives angiogenesis in transcription-independent manner: new function of the master regulator of oxidative stress response345Angiogenic gene therapy, despite efficient vascular growth, is not able to improve muscle function in normoxic or chronically ischemic rabbit hindlimbs -role of capillary arterialization and shunting346Effect of PAR-1 inhibition on collateral vessel growth in the murine hind limb model347Quaking is a key regulator of endothelial cell differentiation, neovascularization and angiogenesis348"Emerging angiogenesis" in the chick chorioallantoic membrane (CAM). An in vivo study349Exosomes from cardiomyocyte progenitor cells and mesenchymal stem cells stimulate angiogenesis in vitro and in vivo via EMMPRINEndothelium352Reciprocal regulation of GRK2 and bradykinin receptor stimulation modulate Ca2+ intracellular level in endothelial cells353The roles of bone morphogenetic proteins 9 and 10 in endothelial inflammation and atherosclerosis354The contribution of GPR55 to the L-alpha-lysophosphatidylinositol-induced vasorelaxation in isolated human pulmonary arteries355The endothelial protective ACE inhibitor Zofenoprilat exerts anti-inflammatory activities through H2S production356A new class of glycomimetic drugs to prevent free fatty acid-induced endothelial dysfunction357Endothelial progenitor cells to apoptotic endothelial cell-derived microparticles ration differentiatesas preserved from reduced ejection fractionheart failure358Proosteogenic genes are activated in endothelial cells of patients with thoracic aortic aneurysm359Endothelin ETB receptors mediate relaxing responses to insulin in pericardial resistance arteries from patients with cardiovascular disease (CVD)Smooth muscle and pericytes362CX3CR1 positive myeloid cells regulate vascular smooth muscle tone by inducing calcium oscillations via activation of IP3 receptors363A novel function of PI3Kg on cAMP regulation, role in arterial wall hyperplasia through modulation of smooth muscle cells proliferation364NRP1 and NRP2 play important roles in the development of neointimal hyperplasia in vivo365Azithromycin induces autophagy in aortic smooth muscle cellsCoagulation, thrombosis and platelets368The real time in vivo evaluation of platelet-dependent aldosterone prothrombotic action in mice369Development of a method for in vivo detection of active thrombi in mice370The antiplatelet effects of structural analogs of the taurine chloramine371The influence of heparin anticoagulant drugs on functional state of human platelets372Regulation of platelet aggregation and adenosine diphosphate release by d dimer in acute coronary syndrome (in vitro study)Oxygen sensing, ischaemia and reperfusion375Sirtuin 5 mediates brain injury in a mouse model of cerebral ischemia-reperfusion376Abscisic acid: a new player in cardiomyocyte protection from ischaemia?377Protective effects of ultramicronized palmitoylethanolamide (PEA-um) in myocardial ischaemia and reperfusion injury in vivo378Identification of stem cell-derived cardiomyocytes using cardiac specific markers and additional testing of these cells in simulated ischemia/reperfusion system379Single-dose intravenous metformin treatment could afford significant protection of the injured rat kidney in an experimental model of ischemia-reperfusion380Cardiotoxicity of long acting muscarinic receptor antagonists used for chronic obstructive pulmonary disease381Dependence antioxidant potential on the concentration of amino acids382The impact of ischemia-reperfusion on physiological parameters,apoptosis and ultrastructure of rabbit myocardium with experimental aterosclerosisMitochondria and energetics385MicroRNA-1 dependent regulation of mitochondrial calcium uniporter (MCU) in normal and hypertrophied hearts386Mitochondrial homeostasis and cardioprotection: common targets for desmin and aB-crystallin387Overexpression of mitofusin-2 (Mfn2) and associated mitochondrial dysfunction in the diabetic heart388NO-dependent prevention of permeability transition pore (MPTP) opening by H2S and its regulation of Ca2+ accumulation in rat heart mitochondria389G protein coupled receptor kinase 2 (GRK2) is fundamental in recovering mitochondrial morphology and function after exposure to ionizing radiation (IR)Gender issues392Sex differences in pulmonary vascular control; focus on the nitric oxide pathwayAging395Heart failure with preserved ejection fraction develops when feeding western diet to senescence-accelerated mice396Cardiovascular markers as predictors of cognitive decline in elderly hypertensive patients397Changes in connexin43 in old rats with volume overload chronic heart failureGenetics and epigenetics400Calcium content in the aortic valve is associated with 1G>2G matrix metalloproteinase 1 polymorphism401Neuropeptide receptor gene s (NPSR1) polymorphism and sleep disturbances402Endothelin-1 gene Lys198Asn polymorphism in men with essential hypertension complicated and uncomplicated with chronic heart failure403Association of common polymorphisms of the lipoprotein lipase and pon1 genes with the metabolic syndrome in a sample of community participantsGenomics, proteomics, metabolomics, lipidomics and glycomics405Gene expression quantification using multiplexed color-coded probe pairs to determine RNA content in sporadic cardiac myxoma406Large-scale phosphorylation study of the type 2 diabetic heart subjected to ischemia / reperfusion injury407Transcriptome-based identification of new anti-inflammatory properties of the olive oil hydroxytyrosol in vascular endothelial cell under basal and proinflammatory conditions408Gene polymorphisms combinations and risk of myocardial infarctionComputer modelling, bioinformatics and big data411Comparison of the repolarization reserve in three state-of-the-art models of the human ventricular action potentialMetabolism, diabetes mellitus and obesity414Endothelial monocyte-activating polypeptide-II improves heart function in type -I Diabetes mellitus415Admission glucose level is independent predictor of impaired left ventricular function in patients with acute myocardial infarction: a two dimensional speckle-tracking echocardiography study416Association between biochemical markers of lipid profile and inflammatory reaction and stiffness of the vascular wall in hypertensive patients with abdominal obesity417Multiple common co-morbidities produce left ventricular diastolic dysfunction associated with coronary microvascular dysfunction, oxidative stress and myocardial stiffening418Investigating the cardiovascular effects of antiretroviral drugs in a lean and high fat/sucrose diet rat model of obesity419Statins in the treatment of non-alcoholic steatohepatitis (NASH). Our experience from a 2-year prospective study in Constanta County, Romania420Epicardial adipose tissue as a predictor of cardiovascular outcome in patients with ACS undergoing PCI?Arterial and pulmonary hypertension423Dependence between heart rhythm disorers and ID polymorphism of ACE gene in hypertensive patients424Molecular mechanisms underlying the beneficial effects of Urocortin 2 in pulmonary arterial hypertension425Inhibition of TGf-b axis and action of renin-angiotensin system in human ascending aorta aneurysms426Early signs of microcirculation and macrocirculation abnormalities in prehypertension427Vascular smooth muscle cell-expressed Tie-2 controls vascular tone428Cardiac and vascular remodelling in the development of chronic thrombo-embolic pulmonary hypertension in a novel swine modelBiomarkers431Arrhythmogenic cardiomyopathy: a new, non invasive biomarker432Can circulating microRNAs distinguish type 1 and type 2 myocardial infarction?433Design of a high-throughput multiplex proteomics assay to identify left ventricular diastolic dysfunction in diabetes434Monocyte-derived and P-selectin-carrying microparticles are differently modified by a low fat diet in patients with cardiovascular risk factors who will and who will not develop a cardiovascular event435Red blood cell distribution width assessment by polychromatic interference microscopy of thin films in chronic heart failure436Invasive and noninvasive evaluation of quality of radiofrequency-induced cardiac denervation in patients with atrial fibrillation437The effect of therapeutic hypothermia on the level of brain derived neurotrophic factor (BDNF) in sera following cardiopulmonary resustitation438Novel biomarkers to predict outcome in patients with heart failure and severe aortic stenosis439Biological factors linking depression and anxiety to cardiovascular disease440Troponins and myoglobin dynamic at coronary arteries graftingInvasive, non-invasive and molecular imaging443Diet composition effects on the genetic typing of the mouse ob mutation: a micro-ultrasound characterization of cardiac function, macro and micro circulation and liver steatosis444Characterization of pig coronary and rabbit aortic lesions using IV-OCT quantitative analysis: correlations with histologyGene therapy and cell therapy447Enhancing the survival and angiogenic potential of mouse atrial mesenchymal cells448VCAM-1 expression in experimental myocardial infarction and its relation to bone marrow-derived mononuclear cell retentionTissue engineering451Advanced multi layered scaffold that increases the maturity of stem cell-derived human cardiomyocytes452Response of engineered heart tissue to simulated ischemia/reperfusion in the presence of acute hyperglycemic conditions453Serum albumin hydrogels prevent de-differentiation of neonatal cardiomyocytes454A novel paintbrush technique for transfer of low viscosity ultraviolet light curable cyan methacrylate on saline immersed in-vitro sheep heart [O] . V Garcia-Martinez, C Lopez Sanchez, W Hamed, 2016

機(jī)譯：早期心臟腔室specification291Bmp2期間海報(bào)會(huì)議2Morphogenetic mechanisms290MiR-133調(diào)控對(duì)視黃酸途徑在早期心臟具有或不具有2型糖尿病mellitus295Association循環(huán)的α2B腎上腺素受體基因插入/缺失多態(tài)性的缺失等位基因和高血壓的formationDevelopmental genetics294Association通過(guò)的miR-130調(diào)節(jié)心房分化陷波的作用：Vascular298Gamma分泌酶抑制劑阻止增殖和動(dòng)脈導(dǎo)管未閉的遷移平滑肌細(xì)胞 - 內(nèi)源性大麻素1型受體（CNR1）與冠狀動(dòng)脈疾?。–AD）的2型糖尿病mellitusCell生長(zhǎng)，分化和干細(xì)胞的G1359A多態(tài)性的在出生后的閉合信令導(dǎo)管arteriosus299Mesenchymal基質(zhì)狀從誘導(dǎo)的多能干細(xì)胞（iPS）衍生的單元（MLC）細(xì)胞：有希望的治療選項(xiàng)，以促進(jìn)neovascularization300Sonic刺猬促進(jìn)間充質(zhì)干細(xì)胞分化為vascula ?平滑肌細(xì)胞cardiovacsular disease301Proinflammatory細(xì)胞因子分泌和在內(nèi)皮細(xì)胞中表觀遺傳學(xué)修飾處理的LPS-GinfivalisCell死亡和細(xì)胞凋亡 - Vascular304Mitophagy充當(dāng)針對(duì)人血管平滑肌細(xì)胞中的保障機(jī)制凋亡誘導(dǎo)動(dòng)脈粥樣硬化lipidsTranscriptional控制和RNA種類(lèi) - 在Vascular307MicroRNA-34a的作用利用后缺氧內(nèi)皮cells310Specific循環(huán)微RNA水平的血管injury309Long非編碼RNA景觀臨床適用的方法衰減新內(nèi)膜形成與miR-146a的抑制劑的血管calcification308Local遞送關(guān)聯(lián)與高血壓，高血糖和功能失調(diào)的HDL在急性冠狀動(dòng)脈綜合征patientsCytokines和細(xì)胞炎癥 - Vascular313Phosphodiesterase5A向上調(diào)控血管內(nèi)皮促炎性條件下進(jìn)行：為ω-3polyunsaturated aatty酸二十二碳六acid31一個(gè)新公開(kāi)的抗炎活性4Cardiovascular風(fēng)險(xiǎn)修改與超低劑量抗細(xì)胞因子藥物在人M-CSF的巨噬細(xì)胞的類(lèi)風(fēng)濕arthritis315Conversion成泡沫細(xì)胞降低了其經(jīng)典M1偏振activation316Lymphocytic心肌炎具有增加斑塊炎癥和在冠狀動(dòng)脈中的斑塊出血一致時(shí)，促進(jìn)心肌infarction317Serum骨保護(hù)素水平的促炎性應(yīng)答通過(guò)抑制手段Heart323A新的合成肽對(duì)肥大體外 - predictsdeclined眾多患者的代謝syndromeGrowth因子和神經(jīng)激素循環(huán)內(nèi)皮 - 衍生的細(xì)胞和單核衍生的祖細(xì)胞 - 胃泌素釋放肽（GRP）對(duì)血管inflammationSignal轉(zhuǎn)導(dǎo)的Vascular320Effect p38的α圖激酶nfkb324Inducible成纖維細(xì)胞特異性敲除是在異丙基腎上腺素誘導(dǎo)的心臟hypertrophy325Regulation的小鼠模型中的心臟保護(hù)β-腎上腺素受體誘發(fā)由抑制性肌力響應(yīng)ORY G蛋白，腺苷酸環(huán)化酶同種型5,6和phosphodiesterases326Binding到RGS3和M2毒蕈堿性乙酰膽堿受體調(diào)制的刺激p190RhoGAP的翻譯后修飾，parylation和脫乙酰化中LMNA的心臟myocytes327Cardiac調(diào)節(jié)底物特異性擴(kuò)張的心肌病小鼠model328Beta腎上腺素能調(diào)節(jié)所述b56delta / PP2A全酶在心肌細(xì)胞通過(guò)b56delta磷酸化絲氨酸573Nitric氧化物和活性氧 - Vascular331Oxidative應(yīng)激誘導(dǎo)的miR-200c的破壞SIRT1，F(xiàn)OXO1和eNOS332Antioxidant療法防止氧化應(yīng)激誘導(dǎo)內(nèi)皮功能障礙和提高之間的調(diào)節(jié)環(huán)路傷口Healing333Morphological和在冠狀動(dòng)脈diseaseCytoskeleton紅細(xì)胞和機(jī)械傳導(dǎo)的生化特征 - Heart336Novel肌球蛋白的活化劑，JSH化合物，ratsExtracellular矩陣增加心肌收縮力沒(méi)有變時(shí)作用和纖維化 - 的Vascular339Ablation Toll樣受體9通過(guò)衰減增殖和心臟fibroblasts340Altered血管在因子VII小鼠后肢缺血模型重塑活化蛋白酶（FSAP）deficiencyVasculogenesis，血管生成和proly的arteriogenesis343Pro血管生成作用的分化導(dǎo)致心肌梗死后心臟破裂羥化酶抑制劑及其在用于冠狀動(dòng)脈總occlusion344Nrf2驅(qū)動(dòng)治療性血管生成的新穎的策略的使用潛在的血管生成轉(zhuǎn)錄非依賴(lài)性方式：氧化應(yīng)激response345Angiogenic基因治療的主調(diào)節(jié)器的新功能，盡管高效血管生長(zhǎng)，不能改善上在鼠后肢側(cè)支血管生長(zhǎng)PAR-1抑制的毛細(xì)動(dòng)脈和shunting346Effect在含氧量正?；蚵匀毖院笾耐眉∪夤δ?Role model347Quaking是內(nèi)皮細(xì)胞分化的關(guān)鍵調(diào)節(jié)劑，新血管形成和angiogenesis348在雞胚絨毛尿囊膜（CAM）“新興血管生成”。一種不同于心肌祖細(xì)胞體內(nèi)study349Exosomes和間充質(zhì)干細(xì)胞刺激血管生成的體外和GRK2的體內(nèi)經(jīng)由EMMPRINEndothelium352Reciprocal調(diào)節(jié)和血管舒緩激肽受體刺激調(diào)制的Ca 2+的細(xì)胞內(nèi)骨的內(nèi)皮cells353The角色形態(tài)發(fā)生蛋白9和10在內(nèi)皮炎癥和atherosclerosis354The貢獻(xiàn)水平GPR55在分離的人將L-α-溶血磷脂酰肌醇誘導(dǎo)的血管舒張肺arteries355The內(nèi)皮保護(hù)ACE抑制劑Zofenoprilat通過(guò)H2S production356A類(lèi)新的糖模擬藥物發(fā)揮抗炎活性，以防止游離脂肪酸誘導(dǎo)的內(nèi)皮dysfunction357Endothelial祖細(xì)胞凋亡的內(nèi)皮細(xì)胞從降低噴射fractionheart failure358Proosteogenic基因保留衍生微粒配給differentiatesas在患者的胸主動(dòng)脈aneurysm359Endothelin ETB REC內(nèi)皮細(xì)胞活化通過(guò)經(jīng)由PI3Kg的對(duì)cAMP調(diào)節(jié)，在動(dòng)脈的作用IP3 receptors363A新穎功能的激活誘導(dǎo)的鈣振蕩eptors調(diào)解放松來(lái)自患有心血管疾?。–VD）的平滑肌和pericytes362CX3CR1陽(yáng)性髓樣細(xì)胞在心包阻力動(dòng)脈到胰島素應(yīng)答調(diào)節(jié)血管平滑肌緊張壁增生，通過(guò)平滑肌細(xì)胞proliferation364NRP1和NRP2的調(diào)制內(nèi)膜增生的發(fā)展vivo365Azithromycin誘導(dǎo)自噬在主動(dòng)脈平滑肌cellsCoagulation，血栓形成和platelets368The實(shí)時(shí)血小板依賴(lài)性醛固酮促血栓形成作用的體內(nèi)評(píng)價(jià)mice369Development玩的方法的重要作用用于體內(nèi)在mice370The活性血栓的檢測(cè)抗血小板的血小板聚集和腺苷的人類(lèi)platelets372Regulation的功能狀態(tài)肝素抗凝藥物的?；撬醕hloramine371The影響結(jié)構(gòu)類(lèi)似物的效果二磷酸酯的釋放通過(guò)d二聚體在急性冠狀動(dòng)脈綜合征（體外研究）氧傳感，局部缺血和腦缺血reperfusion376Abscisic酸的小鼠模型reperfusion375Sirtuin 5介導(dǎo)的腦損傷：在從局部缺血心肌保護(hù)的新播放ultramicronized十六酰胺乙醇的377Protective效果（？ PEA-UM）在干細(xì)胞衍生的心肌細(xì)胞的vivo378Identification心肌缺血再灌注損傷的使用心臟特異性標(biāo)志物，并在這些細(xì)胞中的額外的測(cè)試模擬缺血/再灌注system379Single劑量靜脈二甲雙胍治療能買(mǎi)得起在受傷大鼠腎臟的顯著保護(hù)的長(zhǎng)效用于慢性阻塞性肺disease381Dependence抗氧化潛力上的缺血 - 再灌注的生理參數(shù)，細(xì)胞凋亡和超微結(jié)構(gòu)氨基acids382The沖擊濃度毒蕈堿性受體拮抗劑缺血reperfusion380Cardiotoxicity的實(shí)驗(yàn)?zāi)Ｐ屯眯募?shí)驗(yàn)aterosclerosisMitochondria和energetics385MicroRNA-1在正常線粒體鈣單向轉(zhuǎn)運(yùn)體（MCU）的依賴(lài)性調(diào)節(jié)和肥大hearts386Mitochondrial穩(wěn)態(tài)和心臟保護(hù)：在糖尿病heart388NO結(jié)蛋白和線粒體融合蛋白-2 AB-crystallin387Overexpression（Mfn2的）和相關(guān)的線粒體功能障礙共同目標(biāo)依賴(lài)性預(yù)防通透性轉(zhuǎn)換孔（MPTP）的開(kāi)口由H 2 S和其在大鼠心臟mitochondria389G蛋白偶聯(lián)受體的Ca 2+積累的調(diào)節(jié)激酶2（GRK2）是在回收曝光后線粒體形態(tài)和功能于電離輻射（IR）性別issues392Sex差異基本在肺血管的控制;注重與射血分?jǐn)?shù)一氧化氮pathwayAging395Heart失敗開(kāi)發(fā)當(dāng)饋送西方飲食到衰老加速mice396Cardiovascular標(biāo)志物的中老年大鼠與體積連接蛋白43在老年高血壓patients397Changes認(rèn)知衰退的預(yù)測(cè)過(guò)載慢性心臟failureGenetics和epigenetics400Calcium內(nèi)容在主動(dòng)脈瓣與1G相關(guān)聯(lián)> 2G矩陣男性高血壓并發(fā)和不復(fù)雜的與脂蛋白脂肪酶的常見(jiàn)多態(tài)性與PON1基因的慢性心臟failure403Association與代謝綜合征金屬蛋白酶1個(gè)polymorphism401Neuropeptide受體基因S（NPSR1）多態(tài)性與睡眠disturbances402Endothelin-1基因Lys198Asn多態(tài)性社區(qū)participantsGenomics，蛋白質(zhì)組學(xué)，代謝組樣品中使用復(fù)用顏色編碼的探針對(duì)脂質(zhì)組學(xué)和glycomics405Gene表達(dá)定量，以確定在經(jīng)受的橄欖油的新抗炎性質(zhì)基于injury407Transcriptome-缺血/再灌注鑒定2型糖尿病心臟的零星心臟myxoma406Large規(guī)模磷酸化研究RNA含量羥基酪醇在血管內(nèi)皮細(xì)胞在人類(lèi)心室動(dòng)作potentialMetabolism，糖尿病三個(gè)國(guó)家的最先進(jìn)的車(chē)型在基礎(chǔ)和促炎conditions408Gene多態(tài)性組合和心肌infarctionComputer建模，生物信息學(xué)和復(fù)極儲(chǔ)備的大data411Comparison的風(fēng)險(xiǎn)細(xì)胞和單核細(xì)胞obesity414Endothelial激活多肽-II型糖尿病-I mellitus415Admission葡萄糖水平改善心臟功能的左心室功能受損患者急性心肌梗死的獨(dú)立預(yù)測(cè)因子：二維斑點(diǎn)追蹤超聲心動(dòng)圖脂質(zhì)譜和炎癥反應(yīng)，在高血壓患者腹部obesity417Multiple常見(jiàn)共病血管壁的剛度的生化標(biāo)志物之間ystudy416Association產(chǎn)生左心室冠狀動(dòng)脈微血管功能障礙，氧化應(yīng)激和心肌stiffening418Investigating的抗逆轉(zhuǎn)錄病毒藥物的心血管作用有關(guān)的舒張功能障礙貧和高脂肪/非酒精性脂肪性肝炎（NASH）的治療o(wú)besity419Statins的蔗糖飲食大鼠模型。我們?cè)诳邓固共炜h2年的前瞻性研究經(jīng)驗(yàn)，Romania420Epicardial脂肪組織心血管結(jié)果的ACS患者接受PCI？動(dòng)脈及肺動(dòng)脈hypertension423Dependence心臟節(jié)律disorers和ACE基因ID多態(tài)性與高血壓patients424Molecular機(jī)制背后的有益預(yù)測(cè)在TGF-β軸和在人類(lèi)升主動(dòng)脈中prehypertension427Vascular微循環(huán)和大循環(huán)異常aneurysms426Early跡象腎素 - 血管緊張素系統(tǒng)的動(dòng)作的肺動(dòng)脈hypertension425Inhibition尿皮質(zhì)素2的影響平滑肌細(xì)胞表達(dá)的血管tone428Cardiac鐵2控制和血管重塑在開(kāi)發(fā)在一個(gè)新穎的豬modelBiomarkers431Arrhythmogenic心肌病慢性血栓栓塞性肺動(dòng)脈高壓：一個(gè)新的，非侵入性的biomarker432Can循環(huán)微RNA區(qū)分類(lèi)型1和類(lèi)型2心肌梗塞433Design的高通量含多處？前蛋白質(zhì)組學(xué)測(cè)定，以確定左室舒張功能障礙diabetes434Monocyte衍生和P-選擇攜帶微粒不同由低脂肪飲食的患者心血管危險(xiǎn)因素誰(shuí)將會(huì)和誰(shuí)不會(huì)被開(kāi)發(fā)寬度評(píng)估心血管event435Red血細(xì)胞分布修改在慢性心臟failure436Invasive和患者的治療低溫對(duì)腦的水平心房fibrillation437The效果射頻誘導(dǎo)的心臟去神經(jīng)支配的質(zhì)量的非侵入性評(píng)價(jià)薄膜的多色干涉顯微鏡中的血清衍生的神經(jīng)營(yíng)養(yǎng)因子（BDNF）以下心肺resustitation438Novel生物標(biāo)志物來(lái)預(yù)測(cè)結(jié)果患者心臟衰竭和冠狀動(dòng)脈graftingInvasive，非侵入性和分子imaging443Diet組成的影響?鏈接抑郁和焦慮心血管disease440Troponins和肌紅蛋白動(dòng)態(tài)重度主動(dòng)脈瓣stenosis439Biological因素n中的鼠ob突變的基因分型，：心臟功能，宏觀和微觀循環(huán)和使用IV-OCT定量分析豬冠狀動(dòng)脈和兔子主動(dòng)脈的病變的肝steatosis444Characterization的微超聲表征：與histologyGene療法和細(xì)胞相關(guān)性therapy447Enhancing存活和小鼠心房間充質(zhì)cells448VCAM-1在實(shí)驗(yàn)性心肌梗塞表達(dá)及其與骨髓來(lái)源的單核細(xì)胞retentionTissue engineering451Advanced多層支架增加干細(xì)胞衍生的工程改造的心臟組織的人類(lèi)cardiomyocytes452Response的成熟到模擬缺血/再灌注的血管生成潛力急性高血糖conditions453Serum白蛋白水凝膠的存在防止新生兒cardiomyocytes454A新穎畫(huà)筆技術(shù)的去分化為低粘度的轉(zhuǎn)印紫外光可固化青色甲基丙烯酸酯上的鹽水浸沒(méi)在體外羊心臟

国产bbaaaaa片,成年美女黄网站色视频免费,成年黄大片,а天堂中文最新一区二区三区,成人精品视频一区二区三区尤物

Red Cell Distribution Width (RDW) Index as a Predictor of Severity of Acute Ischemic Stroke: A Correlation Study

摘要

著錄項(xiàng)

引文網(wǎng)絡(luò)

相似文獻(xiàn)

相關(guān)主題

期刊訂閱